Drugs / AD113
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04905979 | Jul 2021 → Jan 2023 | hypertensive disorder, obstructive sleep apnea syndrome | Apnimed | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AD113 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04905979 ↗ |